237
Views
6
CrossRef citations to date
0
Altmetric
Research Article

MicroRNA-206, IL-4, IL-13, and INF-γ levels in lung tissue and plasma are increased by the stimulation of particulate matter with a diameter of ≤2.5μm, and are associated with the poor prognosis of asthma induced pulmonary arterial hypertension patients

, , , ORCID Icon &
Pages 181-188 | Received 21 Aug 2020, Accepted 04 Oct 2020, Published online: 21 Oct 2020

References

  • Huang SJ, Lin LL, Chen LC, Ou LS, Yao TC, Tsao KC, Yeh KW, Huang JL. Prevalence of airway hyperresponsiveness and its seasonal variation in children with asthma. Pediatr Neonatol. 2018;59:561–66. doi:10.1016/j.pedneo.2018.01.005. Cited in: PMID: 29398555.
  • Albers FC, Papi A, Taillé C, Bratton DJ, Bradford ES, Yancey SW, Kwon N. Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: meta-analysis of MENSA and MUSCA. Respir Res. 2019;20:169. doi:10.1186/s12931-019-1134-7. Cited in: PMID: 31362741.
  • Huang K, Yang T, Xu J, Yang L, Zhao J, Zhang X, Bai C, Kang J, Ran P, Shen H, et al. Prevalence, risk factors, and management of asthma in China: a national cross-sectional study. Lancet. 2019;394:407–18. doi:10.1016/S0140-6736(19)31147-X. Cited in: PMID: 31230828.
  • Armstrong M, Vogiatzis I. Personalized exercise training in chronic lung diseases. Respirology. 2019;24:854–62. doi:10.1111/resp.13639. Cited in: PMID: 31270909.
  • Chan K, Coghlan JG, Hall M, Haddock J, Bates A, Schreiber BE. Grossly abnormal ventilation/perfusion SPECT study in idiopathic pulmonary arterial hypertension without thromboembolism. Heart Lung Circ. 2018;27:e101–e104. doi:10.1016/j.hlc.2018.01.001. Cited in: PMID: 29678310.
  • Wang Q, Fan D, Zhao L, Wu WA. Study on the design method of indoor fine particulate matter (PM2.5) pollution control in China. Int J Environ Res Public Health. 2019;16:4588. doi:10.3390/ijerph16234588. Cited in: PMID: 31756898.
  • Haikerwal A, Akram M, Sim MR, Meyer M, Abramson MJ, Dennekamp M. Fine particulate matter (PM2.5) exposure during a prolonged wildfire period and emergency department visits for asthma. Respirology. 2016;21:88–94. doi:10.1111/resp.12613. Cited in: PMID: 26346113.
  • Wang L, Xu J, Liu H, Li J, Hao H. PM2.5 inhibits SOD1 expression by up-regulating microRNA-206 and promotes ROS accumulation and disease progression in asthmatic mice. Int Immunopharmacol. 2019;76:105871. doi:10.1016/j.intimp.2019.105871. Cited in: PMID: 31520993.
  • Yue W, Tong L, Liu X, Weng X, Chen X, Wang D, Dudley SC, Weir EK, Ding W, Lu Z, et al. Short term Pm2.5 exposure caused a robust lung inflammation, vascular remodeling, and exacerbated transition from left ventricular failure to right ventricular hypertrophy. Redox Biol. 2019;22:101161. doi:10.1016/j.redox.2019.101161. Cited in: PMID: 30861460.
  • Chen JJ, Ma WM, Yuan JL, Cui LQ. PM2.5 exposure aggravates left heart failure induced pulmonary hypertension. Acta Cardiol. 2019;74:238–44. doi:10.1080/00015385.2018.1488568. Cited in: PMID: 30348056.
  • Qiu YY, Wu Y, Lin MJ, Bian T, Xiao YL, Qin C. LncRNA-MEG3 functions as a competing endogenous RNA to regulate Treg/Th17 balance in patients with asthma by targeting microRNA-17/RORγt. Biomed Pharmacother. 2019;111:386–94. doi:10.1016/j.biopha.2018.12.080. Cited in: PMID: 30594051.
  • Li R, Zhou R, Zhang J. Function of PM2.5 in the pathogenesis of lung cancer and chronic airway inflammatory diseases. Oncol Lett. 2018;15:7506–14. doi:10.3892/ol.2018.8355. Cited in: PMID: 29725457.
  • Li P, Wang J, Guo F, Zheng B, Zhang X. A novel inhibitory role of microRNA-224 in particulate matter 2.5-induced asthmatic mice by inhibiting TLR2. J Cell Mol Med. 2020;24:3040–52. doi:10.1111/jcmm.14940. Cited in: PMID: 31978265.
  • Abman SH, Hansmann G, Archer SL, Ivy DD, Adatia I, Chung WK, Hanna BD, Rosenzweig EB, Raj JU, Cornfield D, et al. Pediatric pulmonary hypertension: guidelines from the American heart association and American thoracic society. Circulation. 2015;132:2037–99. doi:10.1161/CIR.0000000000000329. Cited in: PMID: 26534956.
  • Huggett JF, Foy CA, Benes V, Emslie K, Garson JA, Haynes R, Hellemans J, Kubista M, Mueller RD, Nolan T, et al. The digital MIQE guidelines: minimum information for publication of quantitative digital PCR experiments. Clin Chem. 2013;59:892–902. doi:10.1373/clinchem.2013.206375. Cited in: PMID: 23570709.
  • Jin Q, Luo Q, Yang T, Zeng Q, Yu X, Yan L, Zhang Y, Zhao Q, Ma X, An C, et al. Improved hemodynamics and cardiopulmonary function in patients with inoperable chronic thromboembolic pulmonary hypertension after balloon pulmonary angioplasty. Respir Res. 2019;20:250. doi:10.1186/s12931-019-1211-y. Cited in: PMID: 31703589.
  • Castellani S, Trapani A, Spagnoletta A, Di Toma L, Magrone T, Di Gioia S, Mandracchia D, Trapani G, Jirillo E, Conese M. Nanoparticle delivery of grape seed-derived proanthocyanidins to airway epithelial cells dampens oxidative stress and inflammation. J Transl Med. 2018;16:140. doi:10.1186/s12967-018-1509-4. Cited in: PMID: 29792199.
  • Huang WC, Fang LW, Liou CJ. Phloretin Attenuates Allergic Airway Inflammation and Oxidative Stress in Asthmatic Mice. Front Immunol. 2017;8:134. doi:10.3389/fimmu.2017.00134. Cited in: PMID: 28243240.
  • Zhang C, Li N, Niu F. Baicalein triazole prevents respiratory tract infection by RSV through suppression of oxidative damage. Microb Pathog. 2019;131:227–33. doi:10.1016/j.micpath.2019.03.026. Cited in: PMID: 30943433.
  • D’Alessandro A, El Kasmi KC, Plecitá-Hlavatá L, Ježek P, Li M, Zhang H, Gupte SA, Stenmark KR. Hallmarks of pulmonary hypertension: mesenchymal and inflammatory cell metabolic reprogramming. Antioxid Redox Signal. 2018;28:230–50. doi:10.1089/ars.2017.7217. Cited in: PMID: 28637353.
  • Goldenberg NM, Rabinovitch M, Steinberg BE. Inflammatory basis of pulmonary arterial hypertension: implications for perioperative and critical care medicine. Anesthesiology. 2019;131:898–907. doi:10.1097/ALN.0000000000002740. Cited in: PMID: 31094755.
  • Spiekerkoetter E, Kawut SM, de Jesus Perez VA. New and emerging therapies for pulmonary arterial hypertension. Annu Rev Med. 2019;70:45–59. doi:10.1146/annurev-med-041717-085955. Cited in: PMID: 30216732.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.